• 1
    Mazzaferri, E.L. (1993) Management of a solitary thyroid nodule. New England Journal of Medicine, 328, 553559.
  • 2
    Gharib, H. & Goellner, J.R. (1993) Fine-needle aspiration biopsy of the thyroid: an appraisal. Annals of Internal Medicine, 118, 282289.
  • 3
    Gharib, H., Goellner, J.R., Zinsmeister, A.R., Grant, C.S. & Van Heerden, J.A. (1984) Fine-needle aspiration biopsy of the thyroid. The problem of suspicious cytologic findings. Annals of Internal Medicine, 101, 2528.
  • 4
    Udelsman, R., Westra, W.H., Donovan, P.I., Sohn, T.A. & Cameron, J.L. (2001) Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid. Annals of Surgery, 233, 716722.
  • 5
    Grieco, M., Santoro, M., Berlingieri, M.T., Melillo, R.M., Donghi, R., Bongarzone, I., Pierotti, M.A., Della Porta, G., Fusco, A. & Vecchio, G. (1990) PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell, 60, 557563.
  • 6
    Nikiforov, Y.E. (2002) RET/PTC rearrangement in thyroid tumors. Endocrine Pathology, 13, 316.
  • 7
    Greco, A., Pierotti, M.A., Bongarzone, I., Pagliardini, S., Lanzi, C. & Della Porta, G. (1992) TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. Oncogene, 7, 237242.
  • 8
    Pierotti, M.A. & Greco, A. (2006) Oncogenic rearrangements of the NTRK1/NGF receptor. Cancer Letters, 232, 9098.
  • 9
    Cohen, Y., Rosenbaum, E., Clark, D.P., Zeiger, M.A., Umbricht, C.B., Tufano, R.P., Sidransky, D. & Westra, W.H. (2004) Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules. Clinical Cancer Research, 10, 27612765.
  • 10
    Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M.J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B.A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G.J., Bigner, D.D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J.W., Leung, S.Y., Yuen, S.T., Weber, B.L., Seigler, H.F., Darrow, T.L., Paterson, H., Marais, R., Marshall, C.J., Wooster, R., Stratton, M.R. & Futreal, P.A. (2002) Mutations of the BRAF gene in human cancer. Nature, 417, 949954.
  • 11
    Kimura, E.T., Nikiforova, M.N., Zhu, Z., Knauf, J.A., Nikiforov, Y.E. & Fagin, J.A. (2003) High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Research, 63, 14541457.
  • 12
    Xu, X., Quiros, R.M., Gattuso, P., Ain, K.B. & Prinz, R.A. (2003) High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Research, 63, 45614567.
  • 13
    Xing, M. (2005) BRAF mutation in thyroid cancer. Endocrine-Related Cancer, 12, 245262.
  • 14
    Baloch, Z.W. & LiVolsi, V.A. (2004) Fine-needle aspiration of thyroid nodules: past, present, and future. Endocrine Practice, 10, 234241.
  • 15
    Sapio, M.R., Posca, D., Troncone, G., Pettinato, G., Palombini, L., Rossi, G., Fenzi, G. & Vitale, M. (2006) Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). European Journal of Endocrinology, 154, 341348.
  • 16
    Ippolito, A.M., De Laurentiis, M., La Rosa, G.L., Eleuteri, A., Tagliaferri, R., De Placido, S., Vigneri, R. & Belfiore, A. (2004) Neural network analysis for evaluating cancer risk in thyroid nodules with an indeterminate diagnosis at aspiration cytology: identification of a low-risk subgroup. Thyroid, 14, 10651071.
  • 17
    Miller, B., Burkey, S., Lindberg, G., Snyder, W.H. III & Nwariaku, F.E. (2004) Prevalence of malignancy within cytologically indeterminate thyroid nodules. American Journal of Surgery, 188, 459462.
  • 18
    Fagin, J.A. (2004) Challenging dogma in thyroid cancer molecular genetics – role of RET/PTC and BRAF in tumor initiation. Journal of Clinical Endocrinology and Metabolism, 89, 42644266.
  • 19
    Unger, K., Zitzelsberger, H., Salvatore, G., Santoro, M., Bogdanova, T., Braselmann, H., Kastner, P., Zurnadzhy, L., Tronko, N., Hutzler, P. & Thomas, G. (2004) Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism, 89, 42724279.
  • 20
    Zhu, Z., Ciampi, R., Nikiforova, M.N., Gandhi, M. & Nikiforov, Y.E. (2006) Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity. Journal of Clinical Endocrinology and Metabolism, 91, 36033610.
  • 21
    Cheung, C.C., Carydis, B., Ezzat, S., Bedard, Y.C. & Asa, S.L. (2001) Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 86, 21872190.